FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

324520007: Product containing precisely metronidazole (as metronidazole benzoate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3692188016 Metronidazole (as metronidazole benzoate) 40 mg/mL oral suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3692189012 Product containing precisely metronidazole (as metronidazole benzoate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Metronidazole (as metronidazole benzoate) 40 mg/mL oral suspension Is a Medicinal product (product) true Inferred relationship Some
Metronidazole (as metronidazole benzoate) 40 mg/mL oral suspension Has manufactured dose form Oral suspension true Inferred relationship Some
Metronidazole (as metronidazole benzoate) 40 mg/mL oral suspension Has basis of strength substance (attribute) Metronidazole (substance) true Inferred relationship Some 1
Metronidazole (as metronidazole benzoate) 40 mg/mL oral suspension Has concentration strength denominator unit mL true Inferred relationship Some 1
Metronidazole (as metronidazole benzoate) 40 mg/mL oral suspension Has concentration strength numerator unit mg true Inferred relationship Some 1
Metronidazole (as metronidazole benzoate) 40 mg/mL oral suspension Has precise active ingredient Metronidazole benzoate (substance) true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

Back to Start